DRF 4832
Latest Information Update: 12 Nov 2004
At a glance
- Originator Dr Reddys Laboratories
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders; Lipid metabolism disorders; Metabolic syndrome
Most Recent Events
- 12 Nov 2004 Discontinued - Preclinical for Cardiovascular disorders in Europe (unspecified route)
- 12 Nov 2004 Discontinued - Preclinical for Lipid metabolism disorders in Europe (unspecified route)
- 12 Nov 2004 Discontinued - Preclinical for Metabolic syndrome in Europe (unspecified route)